NUC.AU Nuchev Ltd
- Market cap
- AUD 12.5M
- P/E
- -
- P/B
- 2.12x
- ROE
- -124.6%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is NUC.AU undervalued?
Graham numberThe Graham number of Nuchev Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nuchev Ltd fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (-124.6%), below 10%.
ROA 0/1
Return on assets (-37.7%) is below the industry median (-3.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-82.0%) is below the industry median (-27.6%).
Revenue Growth 2/2
Revenue grew 43.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (70.7%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.3 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (2.1x) is above the industry median (1.3x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Nuchev Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nuchev Ltd
Nuchev Limited engages in the nutrition and wellness business across consumer, practitioner, distribution, and digital channels in Australia, China, Vietnam, and New Zealand. It offers goat-milk food and beverages; natural liquid vitamins; skincare products; and functional nutrition for weight wellness and vitality under the Oli6, Brauer, Skin Physics, and Rapid Loss brands. The company also provides clinically validated formulations, practitioner education, and professional…
Full company profileNuchev Ltd financial statements
Nuchev Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.54M | 3.44M | 9.50M | 17.8M | 10.9M | 9.72M | 8.79M | 11.3M | 22.9M | 25.7M |
| Gross Profit | -685K | -2.44M | -946K | 5.64M | 3.20M | 2.78M | 1.90M | 3.63M | 10.9M | 3.19M |
| Operating Income | -8.54M | -9.36M | -8.07M | -10.2M | -11.9M | -9.25M | -8.74M | -6.46M | -3.57M | -5.39M |
| EBITDA | -8.33M | -11.5M | -9.79M | -9.87M | -12.4M | -10.9M | -8.57M | -7.18M | -3.62M | -4.76M |
| Net Income | -9.68M | -14.1M | -13.5M | -10.9M | -13.3M | -11.1M | -8.81M | -7.32M | -3.82M | -7.39M |
| EPS | -0.20 | -0.29 | -0.28 | -0.25 | -0.24 | -0.20 | -0.17 | -0.09 | -0.03 | -0.05 |
| Balance Sheet | ||||||||||
| Total Assets | 17.9M | 17.1M | 34.4M | 27.5M | 28.3M | 17.7M | 15.3M | 20.1M | 17.4M | 19.6M |
| Total Liabilities | 15.6M | 21.4M | 1.60M | 2.23M | 1.62M | 1.92M | 2.51M | 5.34M | 6.16M | 13.7M |
| Shareholders' Equity | 2.32M | -4.23M | 32.8M | 25.3M | 26.7M | 15.8M | 12.8M | 14.8M | 11.2M | 5.93M |
| Cash & Short-term Investments | 3.54M | 2.68M | 21.0M | 9.44M | 14.5M | 5.13M | 7.49M | 7.61M | 3.61M | 2.13M |
| Total Debt | 14.8M | 20.2M | 7.75M | 386K | 286K | 154K | 284K | 323K | 393K | 4.19M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -13.2M | -9.06M | -8.64M | -10.7M | -9.49M | -8.30M | -3.26M | -3.73M | -3.74M | -6.64M |
| Capital Expenditure | 722K | 1.55M | 212K | 60.4K | 369K | 5.37K | 127K | 9.74K | 184K | 17.7K |
| Free Cash Flow | -13.9M | -10.6M | -8.85M | -10.8M | -9.86M | -11.6M | -3.38M | -3.74M | -3.93M | -6.66M |
| Ratios | ||||||||||
| ROE | -417.0% | - | -41.2% | -43.1% | -49.7% | -70.2% | -68.7% | -49.6% | -34.0% | -124.6% |
| ROA | -53.9% | -82.1% | -39.2% | -39.6% | -46.9% | -62.6% | -57.5% | -36.4% | -22.0% | -37.7% |
| Net Profit Margin | -380.4% | -409.0% | -142.1% | -61.4% | -121.7% | -114.2% | -100.2% | -64.5% | -16.7% | -28.8% |
| Debt to Equity | 6.38x | - | 0.24x | 0.02x | 0.01x | 0.01x | 0.02x | 0.02x | 0.03x | 0.71x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nuchev Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | AUD 154K | 0.00 | - |
| 2022 | - | - | - |
| 2021 | AUD 118K | 0.00 | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Nuchev Ltd
- Insiders 55.91%
- Institutions 8.01%
- Public & others 36.08%
- Shares outstanding 157M
- Free float 27.3M
Nuchev Ltd company profile
- Company name
- Nuchev Ltd
- Ticker
- NUC.AU
- ISIN
- AU0000067001
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- June
- Address
- 5 Bowen Crescent, Melbourne, VIC, Australia, 3000
- Phone
- 61 3 4222 66570
- Website
- nuchev.com.au
About Nuchev Ltd
Nuchev Limited engages in the nutrition and wellness business across consumer, practitioner, distribution, and digital channels in Australia, China, Vietnam, and New Zealand. It offers goat-milk food and beverages; natural liquid vitamins; skincare products; and functional nutrition for weight wellness and vitality under the Oli6, Brauer, Skin Physics, and Rapid Loss brands. The company also provides clinically validated formulations, practitioner education, and professional support; bioavailable, well-tolerated formulations for energy, muscle, and nervous system support; alkaline mineral formulations; homeopathic solutions; liquid formulations; and herbal remedies under the Bio-Practica, Magnesium Diasporal, Basica, Heel, Brauer Professional, and Medicine Tree brands. In addition, it offers children's snacking products, goat functional food products, and full cream goat milk powder formats. The company sells its products through pharmacy, grocery, retail, and e-commerce channels; and digital platforms, as well as healthcare practitioners, clinics, health food stores, and other specialist channels. Nuchev Limited was incorporated in 2013 and is headquartered in Melbourne, Australia.
Nuchev Ltd management
6- Mr. Ben DingleFounder & Chairman of the Board
- Mr. Nathan Alexander Xavier CheongChief Executive Officer
- Mr. Matthew R. ParkerChief Financial Officer
- Mr. David CurieHead of Sales & Business Development
- Ms. Helen Hovenga B.A., M.B.A.Head of Human Resources
- Ms. Tamara Monica BarrCompany Secretary